Ensuring Bone Health for Adolescents Identifying as Transgender
With a grant from Women's Health Research at Yale, Dr. Stuart Weinzimer, in collaboration with Drs. Thomas Carpenter and Christy Olezeski, is using sophisticated methods to obtain a picture of the dynamic process of bone development in adolescents undergoing gender-affirming hormone therapy.
Women: What's in a Name?
Today, as our scientific and cultural understanding expands, we have learned that sex and gender are not binary. And, in science, as our knowledge grows so must our efforts to welcome everyone in the identities they bring, and to enhance the precision of our language in adopting terms that value everyone. Even so, we must not forget our history and the descriptive terms that serve us well.
Why Is COVID-19 Striking Men Harder Than Women?
Women's Health Research at Yale Director Carolyn M. Mazure and Immunobiology Professor Akiko Iwasaki, discuss how understanding why men suffer more severe cases of COVID-19 and are more likely to die is vital for developing effective strategies that can produce better outcomes for everyone.Source: Time
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
Krystal and Nunez-Smith Are Honored by Association for Clinical and Translational Science
John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research, chair and professor of psychiatry, and professor of neuroscience; and Marcella Nunez-Smith, MD, MHS, associate professor of medicine (general medicine) and of epidemiology (chronic diseases), have been chosen for awards by the Association for Clinical and Translational Science.
New Initiative Will Fund Innovative Solutions in Health Care
The Yale Institute for Global Health (YIGH) has partnered with The CoWrks Foundry and the RMZ Foundation to launch the Sustainable Health Initiative (SHI). SHI will build upon technology and local ingenuity by funding innovative start-ups to create social, health, and environmental impacts.
Vaccine Expert Named First Director of Yale Institute for Global Health
Saad B. Omer, MBBS, MPH, PhD, has been named the inaugural director of the Yale Institute for Global Health (YIGH). Omer is currently the William H. Foege Professor of Global Health, Epidemiology, and Pediatrics at Emory University’s Schools of Public Health and Medicine.
Delphin-Rittmon to Remain Commissioner of DMHAS in Lamont Administration
Miriam E. Delphin-Rittmon, PhD, Associate Professor of Psychiatry at Yale School Medicine, will remain Commissioner of the Connecticut Department of Mental Health and Addiction Services (DMHAS) under the new administration of Governor Ned Lamont.
Bommersbach first author of paper that promotes collaboration between public health, behavioral health
Tanner Bommersbach, MD, MPH, a first-year resident in the Yale Department of Psychiatry, is the first author of a paper published in the American Journal of Public Health that outlines opportunities for collaboration between public health and behavioral health.
Proposed legislation would subject e-cigarettes to age verification law
New legislation proposed June 5 by Congresswoman Rosa DeLauro, D-Conn., would require Internet and mail order sellers of electronic cigarettes to verify a person’s age and identity before they deliver their products to a buyer’s door.
NIDA-funded Yale program announces 23 scientists accepted to inaugural 'Innovation to Impact' training bootcamp
Innovation to Impact, a national program funded by The National Institute on Drug Abuse (NIDA) and hosted at Yale University, has announced the selection of 23 scientists, representing 17 institutions, to comprise the inaugural class of trainees in entrepreneurship to enable rapid deployment of their discoveries into life-saving products to aid Americans suffering from addiction.
The open-access model: A promising model for scaling up opioid agonist treatment
Lynn Madden, PhD, MPA, Postdoctoral Associate, and Declan Barry, PhD, Associate Professor of Psychiatry, are the first and senior authors, respectively, of a paper published in Addiction which demonstrates the promise of their "open-access model" for treating patients with opioid use disorder.